Astrazeneca plc, Pharmaceutical company

There is no signal of concern regarding the use of Oxford-AstraZeneca COVID-19 vaccine in the country, said Dr VK Paul, Member (Health) of the Niti Aayog, on Wednesday amid speculations and subsequent review of possible side-effects of the vaccine."There are reports on AstraZeneca's vaccine relationship with thrombotic events in people who received the vaccine. But the European Medicines Agency (EMA, Europe's top drug agency) says that it (suspension of the vaccine) is only a precautionary measure," Paul said while addressing the weekly press briefing here.Paul added, "There is no data to believe, as of now, that there is a causal relationship, and part of the assessment is still being done. The World Health Orgsation (WHO) has said that the investigation should go on but they have said categorically that the vaccine scale-up and implementation should not be suspended in general."This comes days after several European countries, including Spain, Germany, France, Italy, Netherlands, suspended the use of the Oxford-AstraZeneca COVID-19 vaccine over blood clot concerns.Paul further informed that India's group, which looks at the adverse effects of COVID-19 vaccines, is aware of the issue and is tracking the information in a systematic matter."I assure you that we have no signal of concern in this regard," he said, adding that the inoculation of Covishield, AstraZeneca's vaccine produced in India by the Serum Institute, will go on with full vigour, but will be mindful of developments in this regard.Regarding the issue, Emer Cooke, executive director of the EMA, had earlier said that the agency remains "firmly convinced" the benefits of AstraZeneca's COVID-19 vaccine outweigh the risks of side effects, reported The Hill.As of March 10, the EMA had received 30 reports of blood clotting events from about five million vaccinated people. The safety committee was also looking at "serious thromboembolic events" from the UK, she said.Sweden and Latvia on Tuesday joined Spain, Germany, France, Italy, Netherlands, Ireland, Denmark, Iceland, and Norway in the suspension of the use of AstraZeneca's COVID-19 vaccine.( With inputs from ANI )Disclaimer: This post has been auto-published from an agency feed without any modifications to the text and has not been reviewed by an editor

Astrazeneca PlcFOLLOW

Astrazeneca plc, Latest News

Brussels, March 19 Several European countries have announced they would restart vaccinations with the AstraZeneca Covid-19 jab after the ... ...

The number of COVID-19 cases in Sri Lanka surpassed 89,000 on Friday after over 300 new infections were detected a day earlier, statistics from the Health Ministry showed here. ...

UK Prime Minister Boris Johnson on Thursday announced getting inoculated with the AstraZeneca vaccine the next day. ...

The AstraZeneca coronavirus vaccine is "safe and effective" and the benefits in combating COVID-19 continue to outweigh the risk of side effects, said the European Medicines Agency's (EMA) committee, PRAC, on Thursday after concluding its preliminary ...

Brussels, March 18 The European Medicines Agency (EMA) is due to provide an assessment on Thursday of the safety ... ...

Pakistan Prime Minister Imran Khan on Thursday received his first dose of coronavirus vaccine. This comes a day after the South Asian nation received half a million doses of coronavirus vaccines donated by China. ...

The Union Health Ministry in its weekly press conference said that there is no concern regarding the Indian version of Oxford-AstraZeneca COVID-19 vaccine Covishield and inoculation program will continue to run with full rigour. ...

There is no signal of concern regarding the use of Oxford-AstraZeneca COVID-19 vaccine in the country, said Dr VK Paul, Member (Health) of the Niti Aayog, on Wednesday amid speculations and subsequent review of possible side-effects of the vaccine. ...